Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-01 MCKENZIE DIANA Director Grant or award +1,001 3,604
2024-05-01 MCKENZIE DIANA Director Returned to the company −1,168 2,436
2024-05-01 MCKENZIE DIANA Director Grant or award · Deferred Stock Units +1,168 5,990.48
2024-05-01 Lagarde Michel Director Grant or award · Stock Option (Right to Buy) +3,142 3,142
2024-05-01 Kearney Terrence C Director Grant or award · Stock Option (Right to Buy) +3,142 3,142
2024-05-01 Garber Alan M Director Grant or award · Stock Option (Right to Buy) +3,142 3,142
2024-05-01 CARNEY LLOYD Director Grant or award +1,001 6,319
2024-05-01 Bhatia Sangeeta N. Director Grant or award 10b5-1 +1,001 4,902
2024-04-15 SACHS BRUCE I Director Grant or award · Deferred Stock Units +109.49 $399.58 $44K 14,853.75
2024-04-02 Ambrose Kristen SVP & Chief Accounting Officer Sale 10b5-1 −240 $419.00 $101K 7,500
2024-04-01 Ambrose Kristen SVP & Chief Accounting Officer Shares withheld for taxes 10b5-1 −225 $418.10 $94K 7,740
2024-02-26 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale 10b5-1 −354 $425.70 $151K 55,804
2024-02-26 Sachdev Amit EVP Chief Patient & Ext Af Off Sale 10b5-1 −3,004 $425.70 $1.3M 55,325
2024-02-26 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Sale 10b5-1 −883 $425.70 $376K 15,972
2024-02-26 Arbuckle Stuart A EVP, COO Sale 10b5-1 −5,034 $425.70 $2.1M 49,691
2024-02-26 Ambrose Kristen SVP & Chief Accounting Officer Sale 10b5-1 −883 $425.70 $376K 7,965
2024-02-26 ALTSHULER DAVID EVP, Global Research and CSO Sale 10b5-1 −4,239 $425.70 $1.8M 25,813
2024-02-23 WAGNER CHARLES F JR EVP & Chief Financial Officer Shares withheld for taxes −3,309 $431.79 $1.4M 53,583
2024-02-23 Tatsis Ourania EVP, Chief Reg. & Quality Off. Shares withheld for taxes 10b5-1 −3,309 $431.79 $1.4M 56,158
2024-02-23 Sachdev Amit EVP Chief Patient & Ext Af Off Shares withheld for taxes 10b5-1 −2,469 $431.79 $1.1M 58,329

Page 21 of 27 · 524 trades